Multiple myeloma
Conditions
Interventions
maintain treatment:thalidomide and Clarithromycin
Sponsors
Shanghai Changzheng Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) More than 18 years old and less than 70 years old; 2) MM patients with measurable disease in accordance with the guidelines; 3) After three drug combination including bortezomib based induction therapy, the patients achieve CR.
Exclusion criteria
Exclusion criteria: 1) Had received anti myeloma treatment (not including radiotherapy, bisphosphonates or single short-term hormone therapy is less than or equal to 40mg/d, 4 day prednisone dose in group 14 days not short-term treatment of it); 2) Primary or secondary plasma cell leukemia; 3) HIV positive, hepatitis A, hepatitis B, hepatitis C infection or disease; hepatitis B virus or DNA copy number > 10^4; liver function index >2.5 * normal high limit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival; | — |
Countries
China
Contacts
Public ContactHou Jian
Shanghai Changzheng Hospital
Outcome results
None listed